Published in Circ Res on May 22, 2009
JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell (1994) 16.30
A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene. Nature (1982) 11.92
The p21 src genes of Harvey and Kirsten sarcoma viruses originate from divergent members of a family of normal vertebrate genes. Nature (1981) 8.44
Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo. Nat Med (1995) 1.81
Ras target proteins in eukaryotic cells. FASEB J (1995) 1.77
Platelet-derived growth factor binds specifically to receptors on vascular smooth muscle cells and the binding becomes nondissociable. Proc Natl Acad Sci U S A (1982) 1.34
Antisense nonmuscle myosin heavy chain and c-myb oligonucleotides suppress smooth muscle cell proliferation in vitro. Circ Res (1992) 1.14
Expression of the c-myb proto-oncogene in bovine vascular smooth muscle cells. J Biol Chem (1992) 1.05
Localisation of the human N-ras oncogene to chromosome 1cen - p21 by in situ hybridisation. EMBO J (1983) 1.02
Forging a path to the nucleus. Science (1993) 1.01
Cultured human atherosclerotic plaque smooth muscle cells retain transforming potential and display enhanced expression of the myc protooncogene. Am J Pathol (1991) 0.97
Short-term local delivery of an inhibitor of Ras farnesyltransferase prevents neointima formation in vivo after porcine coronary balloon angioplasty. Circulation (2001) 0.96
Adenovirus-mediated transfer of a dominant-negative H-ras suppresses neointimal formation in balloon-injured arteries in vivo. Arterioscler Thromb Vasc Biol (1997) 0.90
Redox regulation of c-Ha-ras and osteopontin signaling in vascular smooth muscle cells: implications in chemical atherogenesis. Annu Rev Pharmacol Toxicol (1999) 0.89
3-Deazaadenosine prevents smooth muscle cell proliferation and neointima formation by interfering with Ras signaling. Circ Res (2009) 0.87
The induction of proliferative vascular smooth muscle cell phenotypes by benzo(a)pyrene is characterized by up-regulation of inositol phospholipid metabolism and c-Ha-ras gene expression. Arch Biochem Biophys (1996) 0.87
Modulation of protooncogene expression in rat aortic smooth muscle cells by benzo[a]pyrene. Arch Biochem Biophys (1993) 0.82
Growth factors and the vessel wall. Prog Hemost Thromb (1982) 0.82
c-myc in vasculoproliferative disease. Circ Res (1995) 0.81
c-Ha-rasEJ transfection of rat aortic smooth muscle cells induces epidermal growth factor responsiveness and characteristics of a malignant phenotype. J Cell Physiol (1994) 0.79
c-Ha-rasEJ transfection in vascular smooth muscle cells circumvents PKC requirement during mitogenic signaling. Am J Physiol (1997) 0.78
Cyclic AMP inhibits c-Ha-ras protooncogene expression and DNA synthesis in rat aortic smooth muscle cells. Experientia (1993) 0.77
Unraveling gene-gene interactions regulated by ligands of the aryl hydrocarbon receptor. Environ Health Perspect (2004) 1.70
Meeting report: hazard assessment for nanoparticles--report from an interdisciplinary workshop. Environ Health Perspect (2007) 1.64
Epigenetic control of mammalian LINE-1 retrotransposon by retinoblastoma proteins. Mutat Res (2009) 1.27
Activation of human long interspersed nuclear element 1 retrotransposition by benzo(a)pyrene, an ubiquitous environmental carcinogen. Cancer Res (2006) 1.18
Context-specific regulation of LINE-1. Genes Cells (2007) 1.07
A stochastic model of gene transcription: an application to L1 retrotransposition events. J Theor Biol (2006) 1.06
Reactivation of L1 retrotransposon by benzo(a)pyrene involves complex genetic and epigenetic regulation. Epigenetics (2011) 1.03
Ligand-activated Ahr signaling leads to disruption of nephrogenesis and altered Wilms' tumor suppressor mRNA splicing. Oncogene (2003) 0.98
Redox regulation of a novel L1Md-A2 retrotransposon in vascular smooth muscle cells. J Biol Chem (2003) 0.95
Disruption of glomerular cell-cell and cell-matrix interactions in hydrocarbon nephropathy. Am J Physiol Renal Physiol (2005) 0.93
The promise and failures of epigenetic therapies for cancer treatment. Cancer Treat Rev (2013) 0.93
Sequence analysis of RNase MRP RNA reveals its origination from eukaryotic RNase P RNA. RNA (2006) 0.91
A surprisingly large RNase P RNA in Candida glabrata. RNA (2005) 0.90
Environmental risk factors of disease in the Cameron Park Colonia, a Hispanic community along the Texas-Mexico border. J Immigr Minor Health (2008) 0.88
Validation of a mathematical model of gene transcription in aggregated cellular systems: application to l1 retrotransposition. J Comput Biol (2007) 0.87
Polycyclic aromatic hydrocarbon-inducible DNA adducts: evidence by 32P-postlabeling and use of knockout mice for Ah receptor-independent mechanisms of metabolic activation in vivo. Int J Cancer (2003) 0.87
The involvement of copper transporter in lead-induced oxidative stress in astroglia. Neurochem Res (2005) 0.87
Plasma membrane Ca(2+) -ATPase associates with CLP36, alpha-actinin and actin in human platelets. Thromb Haemost (2007) 0.85
Embracing the local: enriching scientific research, education, and outreach on the Texas-Mexico border through a participatory action research partnership. Environ Health Perspect (2003) 0.84
Insight into redox-regulated gene networks in vascular cells. Bioinformation (2007) 0.83
The atherogen 3-methylcholanthrene induces multiple DNA adducts in mouse aortic smooth muscle cells: role of cytochrome P4501B1. Cardiovasc Res (2002) 0.83
Activation profiles of HSPA5 during the glomerular mesangial cell stress response to chemical injury. Cell Stress Chaperones (2007) 0.82
Modulation of alpha7-integrin-mediated adhesion and expression by platelet-derived growth factor in vascular smooth muscle cells. Am J Physiol Cell Physiol (2005) 0.81
Reprogramming of the HepG2 genome by long interspersed nuclear element-1. Mol Oncol (2013) 0.81
Role of cytochrome P4501B1 in benzo[a]pyrene bioactivation to DNA-binding metabolites in mouse vascular smooth muscle cells: evidence from 32P-postlabeling for formation of 3-hydroxybenzo[a]pyrene and benzo[a]pyrene-3,6-quinone as major proximate genotoxic intermediates. J Pharmacol Exp Ther (2003) 0.81
Regulation of alpha7-integrin expression in vascular smooth muscle by injury-induced atherosclerosis. Am J Physiol Heart Circ Physiol (2004) 0.81
Collagen suppresses the proliferative phenotype of allylamine-injured vascular smooth muscle cells. Atherosclerosis (2002) 0.81
Osteopontin regulates α-smooth muscle actin and calponin in vascular smooth muscle cells. Cell Biol Int (2012) 0.80
Rpm2p, a protein subunit of mitochondrial RNase P, physically and genetically interacts with cytoplasmic processing bodies. Nucleic Acids Res (2007) 0.80
The development of abdominal aortic aneurysms in mice is enhanced by benzo(a)pyrene. Vasc Health Risk Manag (2008) 0.80
NF-κB and matrix-dependent regulation of osteopontin promoter activity in allylamine-activated vascular smooth muscle cells. Oxid Med Cell Longev (2012) 0.80
In vitro models to evaluate acute and chronic injury to the heart and vascular systems. Toxicol In Vitro (2005) 0.79
GRP78 compartmentalized redistribution in Pb-treated glia: role of GRP78 in lead-induced oxidative stress. Neurotoxicology (2005) 0.79
Differential profiles of copper-induced ROS generation in human neuroblastoma and astrocytoma cells. Brain Res Mol Brain Res (2005) 0.78
A mutant Ahr allele protects the embryonic kidney from hydrocarbon-induced deficits in fetal programming. Environ Health Perspect (2011) 0.77
HPV E7 viral oncoprotein disrupts transcriptional regulation of L1Md retrotransposon. FEBS Lett (2011) 0.77
Calmodulin involvement in stress-activated nuclear localization of albumin in JB6 epithelial cells. Biochemistry (2004) 0.77
AHR regulates WT1 genetic programming during murine nephrogenesis. Mol Med (2011) 0.77
Retinoblastoma family of proteins and chromatin epigenetics: a repetitive story in a few LINEs. Biomol Concepts (2011) 0.77
Modulation of cyclin dependent kinase inhibitor proteins and ERK1/2 activity in allylamine-injured vascular smooth muscle cells. J Cell Biochem (2004) 0.76
Activation of group IVC phospholipase A(2) by polycyclic aromatic hydrocarbons induces apoptosis of human coronary artery endothelial cells. Arch Toxicol (2010) 0.75
Decoding the riddle: the dawn of RNAi for the study of gene-gene and gene-environment interactions. Environ Health Perspect (2004) 0.75
DNA sequence determinants of nuclear protein binding to the c-Ha-ras antioxidant/electrophile response element in vascular smooth muscle cells: identification of Nrf2 and heat shock protein 90 beta as heterocomplex components. Cell Stress Chaperones (2005) 0.75
Characterization of glomerular cell phenotypes following repeated cycles of benzo[a]pyrene injury in vitro. Biochem Pharmacol (2002) 0.75
Health status, perceptions and needs of Hispanics in rural Shelbyville, Kentucky. J Immigr Minor Health (2015) 0.75
Reading Between the Genes: Computational Models to Discover Function from Noncoding DNA. Pac Symp Biocomput (2018) 0.75
EHP Toxicogenomics: a publication forum in the postgenome era. EHP Toxicogenomics (2003) 0.75
Modulation of alpha4 integrin mRNA levels is coupled to deficits in vasomotor function in rat arterioles by allylamine. Life Sci (2005) 0.75